Phase I dose-escalation study of copanlisib in combination with gemcitabine or cisplatin plus gemcitabine in patients with advanced cancer

Por Kim, R D, Alberts, S R, Peña, C, Genvresse, I, Ajavon-Hartmann, A, Xia, C, Kelly, A, Grilley-Olson, J E
Publicado no Br J Cancer (2018)

Different cellular p16(INK4a) localisation may signal different survival outcomes in head and neck cancer

Por Zhao, N, Ang, M-K, Yin, X-Y, Patel, M R, Fritchie, K, Thorne, L, Muldrew, K L, Hayward, M C, Sun, W, Wilkerson, M D, Chera, B S, Hackman, T, Zanation, A M, Grilley-Olson, J E, Couch, M E, Shockley, W W, Weissler, M C, Shores, C G, Funkhouser, W K, Olshan, A F, Hayes, D N
Publicado em 2012